Anika Therapeutics | ANIK - Debitur Perdagangan





Debitur Perdagangan Perubahan Tanggal
Abbott USD 10.57B 171M 2025-12
Agenus USD 22.44M 1.14M 2025-12
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Anika Therapeutics USD 29.33M 661K 2025-12
Arrowhead Research USD 15.68M 203.19M 2026-03
Enanta Pharmaceuticals USD 40.16M 1.52M 2024-12
Halozyme Therapeutics USD 457.99M 16.72M 2026-03
Heron Therapeutics USD 89.59M 8.54M 2025-12
Insmed USD 178.55M 37.7M 2026-03
Integra LifeSciences USD 264.41M 14.44M 2026-03
Intrexon USD 1.02M 559K 2024-06
J&J USD 21.33B 3.72B 2025-12
Karyopharm Therapeutics USD 26.18M 5.6M 2025-12
Ligand Pharmaceuticals USD 54.8M 6.25M 2026-03
MacroGenics USD 13.37M 55.86M 2025-12
Merit Medical Systems USD 227M 3.39M 2026-03
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 482M 85M 2026-03
Smith & Nephew USD 1.48B 85M 2025-12
Stryker USD 3.57B 468M 2026-03
Surmodics USD 23.56M 288K 2025-06
Veracyte USD 50.11M 5.45M 2026-03
Xencor USD 12M 17.3M 2026-03
Zimmer Biomet Holdings USD 1.73B 24.2M 2026-03